Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Dilevalol

Known as: Labetalol, (R,R)-Isomer, R,R Labetalol, R,R-Labetalol 
National Institutes of Health

Related topics

Related topics

2 relations

Broader (1)

Labetalol
SCH-19927

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
1998
Review
1998
Antihypertensive therapy and insulin sensitivity: do we have to redefine the role of beta-blocking agents?
Essential hypertension is, at least in many subjects, associated with a decrease in insulin sensitivity, whereas glycemic control… Expand
  • table 1
  • figure 1
  • figure 2
  • figure 3
  • table 2
1991
1991
The effects of age on the pharmacokinetics, antihypertensive efficacy and general tolerability of dilevalol.
1. This study investigated the influence of age on the pharmacokinetics, pharmacodynamics, general tolerability and concentration… Expand
Review
1990
Review
1990
Dilevalol. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in hypertension.
Dilevalol, the RR-stereoisomer of labetalol, is a non-cardioselective beta-adrenoceptor antagonist with substantial partial beta… Expand
  • figure 1
  • table I
  • figure 2
  • figure 3
  • table II
1990
1990
Double-Blind Study of Dilevalol and Captopril, Both in Combination with Hydrochlorothiazide, in Patients with Moderate to Severe Hypertension
Summary: Sixty-one patients (41 men, 20 women) aged 29-73 years, with moderate to severe hypertension, were enrolled in a… Expand
Highly Cited
1989
Highly Cited
1989
Arterial dilation and reduced wave reflection. Benefit of dilevalol in hypertension.
We compared dilevalol (an isomer of labetalol), 200-400 mg daily, against atenolol, 50-100 mg daily, in a double-blind, crossover… Expand
  • table 1
  • figure 1
  • figure 2
  • figure 3
  • figure 4
1989
1989
Influence of beta 2 agonism and beta 1 and beta 2 antagonism on adverse effects and plasma lipoproteins: results of a multicenter comparison of dilevalol and metoprolol.
Dilevalol combines vasodilation due to selective beta 2 agonism and nonselective beta antagonism. We studied 311 patients… Expand
1988
1988
Pharmacokinetics and Bioavailability of Dilevalol in Normotensive Volunteers
The bioavailability and pharmacokinetics of dilevalol following oral and intravenous administration were investigated in 12… Expand
1988
1988
The effects of dilevalol, metoprolol, and placebo on ventilatory function in asthmatics.
Dilevalol combines a nonselective blocking action on beta-receptors with selective beta 2-agonist activity. In this double-blind… Expand
1988
1988
High-performance liquid chromatographic assay for dilevalol in human plasma and urine using a PRP-1 column and fluorimetric detection.
A single high-performance liquid chromatographic (HPLC) assay for the quantitative determination of dilevalol, the R,R isomer of… Expand
1988
1988
Actions of dilevalol on adrenoceptors.
It is not surprising that there has been a search for compounds that combine two useful antihypertensive properties. The… Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy, Terms of Service, and Dataset License
ACCEPT & CONTINUE